Description
REGENFLEX® is a medical device based on a highly-purified Hyaluronic Acid, with molecular weight between 800-1.200 kDalton.
Sodium hyaluronate is a fundamental component of the synovial fluid, as it is responsible of the visco-elastic properties of the latter.
The sodium hyaluronate contained in REGENFLEX® is obtained by means of fermentation, avoiding any kind of chemical modification treatment, in order to guarantee an absolutely pure product, free of remains alien to the physiological context of implementation.
REGENFLEX® STARTER and REGENFLEX® are injectable products based on a buffered physiological solution (respectively 1,6% and 0,8%) of hyaluronic acid sodium salt with significant viscoelastic properties.
The packages include one single-use syringe, containing 2ml of sterile apyrogen solution.
